GSK plc announced the purchase of 477,000 ordinary shares on February 24, 2026, as part of its buyback program, resulting in a total of 2,706,000 shares bought since February 17, 2026. The shares were bought at prices between 2,175.00p and 2,217.00p each, with an average price of 2,200.50p.